Orthofix Medical Inc

NASDAQ OFIX

Data sourced from iex and EODHD
Download Data

Orthofix Medical Inc Interest Expense To Sales 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending March 31, 2024: 539.85%

Orthofix Medical Inc Interest Expense To Sales 1 year YoY Change (%) is 539.85% for the Trailing 12 Months (TTM) ending March 31, 2024, a 28,530.84% change year over year. The interest expense to sales ratio is a financial metric that represents the proportion of a company's revenue that is used to cover its interest expenses. It is calculated by dividing the company's interest expense by its total revenue. This ratio indicates the financial burden of interest payments on the company's operating income. A higher ratio suggests that a significant portion of the company's revenue is being used to service interest obligations, potentially affecting its profitability. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Orthofix Medical Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2023 was 0.38%, a -1.90% change year over year.
  • Orthofix Medical Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2022 was 0.39%, a -41.78% change year over year.
  • Orthofix Medical Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2021 was 0.66%, a 91.68% change year over year.
  • Orthofix Medical Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2020 was 0.35%, a 72.83% change year over year.
NASDAQ: OFIX

Orthofix Medical Inc

CEO Mr. Jon C. Serbousek
IPO Date April 24, 1992
Location United States
Headquarters 3451 Plano Parkway, Lewisville, TX, United States, 75056
Employees 1,634
Sector Healthcare
Industry Medical devices
Description

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

StockViz Staff

September 20, 2024

Any question? Send us an email